clostridium beijerinckii
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2026 (NCT06992154)
Timeline
2020s
- Jan 1, 2026
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Clostridium beijerinckiiSupplementation
Clostridium beijerinckii supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06992154 | Early Phase 1 (Phase 1) | Mar 31, 2026 | Medical University of South Carolina, Pendulum Therapeutics |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical University of South Carolina | Academic/Hospital | 1 | 1 | 1 | 2026 |
| Pendulum Therapeutics | For profit | 1 | 0 | 1 | 2026 |
2 organizations
Page 1 / 1